Journal of Urology

📘 The July issue of The Journal of Urology is live! From updated prostate cancer guidelines to advances in biomarkers, imaging, and innovative treatments, this issue highlights the research shaping the future of urologic care. 🔬 🔗 Read the issue now: bit.ly/4xtso1z

🪨 Does Lower Pole Stone Location Impact Pediatric Ureteroscopy? A study finds that lower pole (LP) kidney stones don't impede success in pediatric flexible ureteroscopy if procedural strategies are optimized. 🔍 Not a Barrier - LP location isn't a standalone predictor of surgical failure ⏱️ Success Factors - Preoperative stenting increases stone-free rates ⚙️ Time Matters - Longer operations boost success in fragment clearance #PediatricUrology #Ureteroscopy #KidneyStones tnyp.me/QqFGuOOU/x

🔬 Optimizing Bladder Cancer Treatment? An editorial highlights the promise of intravesical cabazitaxel, gemcitabine, & cisplatin for BCG-unresponsive NMIBC. 🧪 Evidence - CGC shows 73% RFS at 12 months ⚠️ Caution - More randomized trials needed 💡 Impact - Could guide future cost-effective treatments #Urology #CancerResearch #MedicalInnovation tnyp.me/nKVHnuYW/x

🚫 Is Cystectomy the Only Option for NMIBC? A phase 2 study explores intravesical cabazitaxel, gemcitabine, and cisplatin for BCG-unresponsive bladder cancer, offering a potential bladder-sparing alternative. 🔬 Recurrence-Free - 73% RFS at 12 months 🛡️ Safe - Limited to grade 1 & 2 toxicities 💡 Promising - A new hope for non-surgical treatment #BladderCancer #NMIBC #Oncology tnyp.me/gWn3yLdT/x

🔍 Can Urinary Proteomics Revolutionize Diagnosis? An editorial highlights a proof-of-concept study using urinary proteomics to differentiate UPJO from VUR in children, promising a leap in precision diagnostics. 🧪 Evidence: 125 distinct protein signatures identified for VUR and UPJO 🎯 ⚠️ Caution: Requires validation across diverse patient groups to ensure accuracy 💡 Impact: Potential to move beyond imaging to biomarker-driven clinical decisions #PediatricUrology #Biomarkers #Proteomics tnyp.me/yus8T5ID/x

🔬 Can Urine Proteins Diagnose Pediatric Urinary Conditions? A study shows urinary proteome can noninvasively differentiate ureteropelvic junction obstruction (#UPJO) from vesicoureteral reflux (#VUR). #Proteomics 🔍 Predictive Models - Achieved 93% accuracy in distinguishing UPJO from VUR. 🧪 Key Proteins - Identified 125 differentially expressed proteins. 🔬 Future Potential - Could replace invasive diagnostics, revolutionizing pediatric care. tnyp.me/GkcqnbSI/x

🔬 Overnight Bladder Drainage: A Game Changer? This study evaluates the role of overnight bladder drainage (OBD) in improving urinary tract health after posterior urethral valve ablation (EVA) in boys. 🔄 Enhanced Function - OBD significantly boosts hydronephrosis, bladder dynamics, and daytime continence 😌 High Tolerability - 87% of patients tolerated OBD well 🚸 Unresolved Queries - Long-term effects and optimal OBD duration remain unclear #Pediatrics #Urology tnyp.me/E8BpkmSC/x

🔍 Does Overnight Bladder Drainage Hold Promise? An editorial explores OBD's potential benefits post-urethral valve ablation in boys but calls for more data. 🧪 Evidence - Study shows short-term bladder improvements ⚠️ Caution - Patient attrition impacts study power 💡 Impact - Encourages further research on OBD vs CIC #BladderHealth #PediatricUrology tnyp.me/6C21JRqf/x

🔍 Can Overnight Bladder Drainage Revolutionize Post-Op Care for Boys? Dr. Ahmed Elkashef shares his thoughts on the recent article, “Efficacy and Tolerability of Overnight Bladder Drainage After Posterior Urethral Valve Ablation on Upper and Lower Urinary Tracts: A Randomized Controlled Trial.” Explore more: tnyp.me/E8BpkmSC/x #Urology #ChildHealth #RCT

🔍 Rethinking Lymph Node Dissection? An editorial comment suggests distal ureteral tumors may spread directly to retroperitoneal nodes, skipping the pelvis, prompting surgical strategy reconsideration. 🧪 Evidence - Distal tumors bypass pelvic nodes ⚠️ Caution - Broader lymphadenectomy may not benefit all 💡 Impact - Insights influence pre-operative imaging & surgical plans #Urology #UTUC #ClinicalResearch tnyp.me/N4OIRQBv/x

🔬 Patterns of Lymph Node Metastases in Ureteral Cancer This study maps lymph node metastasis (LNM) patterns in mid and distal ureteral tumors to refine surgical templates, crucial for cancer staging and treatment. 🔎 Largest to Date - Analyzes 45 LNMs in 24 patients 🦠 Retroperitoneal LNM - Found in 53% of mid and 39% of distal tumors 📈 Implications - Supports retroperitoneal LND in clinical practice #Urology #CancerResearch #LymphNodeMapping #UTUC tnyp.me/cEjLsI4I/x

💦 Is 24-Hour Urine Testing Essential? An editorial assesses the necessity and effectiveness of 24-hour urine tests in kidney stone prevention. 🧪 Evidence - Personalized medicine demands a selective approach. ⚠️ Caution - High attrition may skew results; long-term adherence varies. 💡 Impact - Empiric treatment suggested for those avoiding testing. #KidneyStones #MedicalResearch tnyp.me/DCLIzOyA/x

Kidney Stone Prevention: Empiric vs. Selective Therapy Does testing enhance kidney stone prevention? The URINE Trial finds no significant difference in stone risk between empiric and selective therapies. 🔬 No Difference - No significant change in calcium oxalate or phosphate supersaturation 💊 Medication Use - 44% of selective therapy participants required indapamide & potassium citrate ⏳ Time Constraints - 8-week follow-up limits long-term conclusions #KidneyStones #ClinicalTrial #Nephrology tnyp.me/ytxoJ9mM/x

🔬 Can Water Vapor Treat Prostate Cancer? @RenaMalikMD discusses how the VAPOR 2 study assesses the effectiveness of water vapor therapy for localized prostate cancer, offering a new treatment with fewer side effects. 🔍 75% Benign Results - 6-month biopsies show benign tissues in most treated men 📉 PSA Reduction - PSA levels dropped by 58% post-treatment 🛠️ Safe Procedure - Minimal side effects; functions near baseline by 12 months #ProstateCancer #VaporTherapy #MedicalInnovation tnyp.me/nUstPIKb/x

The November issue of The Journal of Urology® is here. 📖 From preventing recurrent kidney stones and advancing bladder cancer treatment to improving prostate cancer screening decisions and uncovering long-term outcomes after prostate cancer therapy, this month's issue highlights research shaping the future of urologic care. Explore new findings across stone disease, oncology, reconstruction, pediatrics, neurourology, and patient decision-making, accompanied by expert editorial perspectives that put the science into clinical context. 🔗 Read the November issue today. tnyp.me/OQ4d0VZ6/x

🧪 Rethinking Uric Acid Stone Treatment? An editorial comment suggests a new approach using phentermine/topiramate to treat uric acid stones effectively. 🧪 Evidence - Intervention showed pH & citrate improvement ⚠️ Caution - Study not practice-changing yet 💡 Impact - May address obesity, insulin resistance through one pill #KidneyStones #Urology #MedicalResearch tnyp.me/BWaGZY3B/x

🔬 Can a Combo Drug Reduce Uric Acid Stones? A study examines phentermine/topiramate for obese, diabetic uric acid stone formers. 🪨 Stone Reduction - Participants saw a 52% decrease in stone volume. ⚖️ Weight Loss - Significant weight reduction achieved. 📈 pH Improvement - Urine pH levels markedly increased. #Urology #Diabetes #Obesity tnyp.me/UjtIT1lK/x

🎯 Intravesical Gem/Doce for NMIBC: A BCG Alternative? An editorial comment examines the potential of gemcitabine-docetaxel (Gem/Doce) as a first-line therapy for BCG-naïve high-risk NMIBC. 🧪 Evidence - Promising 3-year outcomes with 80% recurrence-free survival ⚠️ Caution - Small sample, nonrandomized study 💡 Impact - Could fill treatment gaps amid BCG supply issues #BladderCancer #BCG #GemDoce #CancerResearch tnyp.me/mF7QzvD9/x

🎯 MRI-Targeted Biopsy: A Game Changer for Prostate Cancer? A multi-institutional study uncovers the power of MRI-targeted transperineal biopsies in improving prostate cancer detection and potential management changes. 🔎 Enhanced Detection - MRI-targeted improves detection of high-grade cancer in 27.4% of patients. 🛑 Omission Option - Systematic biopsy could be omitted in 83% but risks missing significant cancer in 17%. 🤔 Patient Decisions - Results stress the need for shared decision-making based on patient risk tolerance. #ProstateCancer #MRI #BiopsyResearch tnyp.me/2o1avJpT/x

💧 Can Water Vapor Revolutionize Prostate Cancer Treatment? An editorial highlights water vapor ablation for intermediate-risk prostate cancer but notes more data is needed for confident positioning. 🧪 Evidence - Initial results show promise but lack long-term data ⚠️ Caution - Do not generalize current findings 💡 Impact - Could enrich focal therapy options in the future #ProstateCancer #WaterVaporTherapy #Research tnyp.me/tNhVkzJN/x

💨 Water Vapor Therapy Revolution in Prostate Cancer Treatment? The VAPOR 2 study reveals water vapor therapy's potential in managing intermediate-risk prostate cancer (PCa). #ProstateCancer #VAPOR2Study 🔬 Efficacy - 75% showed benign tissue 6 months post-treatment 📉 PSA Decline - Median PSA levels fell by 58% 💪 Safety - Mild adverse events resolved without long-term effects Explore more at: tnyp.me/nUstPIKb/x